Expression Analysis Welcomes New Vice President of Operations

DURHAM, N.C.--(BUSINESS WIRE)-- EA, a leading provider of genetic and genomic testing and analysis for the pharmaceutical and biotechnology industries, is pleased to announce the addition of Tyler Aldredge to its executive management team. Tyler will assume the role of Vice President of Laboratory Operations.

Tyler has a wealth of genomics experience in both clinical and research laboratories. Most recently, Tyler held the position of Director of Laboratory Operations at Genzyme Genetics, a clinical laboratory which provides a variety of genetic and specialty laboratory tests to physicians all over the world. Prior to his tenure with Genzyme Genetics, Tyler was employed by the Broad Institute, Harvard University Center for Genomic Research, Sanofi, Codon Devices and Genome Therapeutics Corporation. Tyler received a BS in Bioengineering from Syracuse University and a Masters in Biomedical Engineering from the Worcester Polytechnic Institute.

“Tyler’s background in engineering, laboratory operations and genomics makes him an ideal candidate to lead our world class operations team at EA,” says Steve McPhail, CEO and President of EA. “Tyler possesses the necessary skill set to lead EA as it continues to grow and expand its service offerings; he will add tremendous benefit to our clients and have a positive impact on our operations, culture and future growth strategies.”

About Expression Analysis

Expression Analysis (www.ExpressionAnalysis.com) provides whole genome to focused set gene expression and genotyping assays along with DNA sequencings services, sequence enrichment technologies and bioinformatics support. Platforms utilized include Affymetrix GeneChip®, Agilent Sure Select Target Enrichment System, Fluidigm’s Biomark and Access Array Systems, Illumina BeadChip®, iScan, HiSeq and Genome Analyzer, Raindance Technologies RDT 1000 and the Pacific Biosciences PacBio RS. Expression Analysis offers solutions for challenging specimens such as whole blood and FFPE tissues, as well as nucleic acid isolation and data analysis services. Our quality system follows CLSI guidelines and our CLIA-registered laboratory supports GLP compliance.



CONTACT:

Expression Analysis
Karen Michailo, 919-287-4277
Cell: 919-349-3687
[email protected]

KEYWORDS:   United States  North America  North Carolina

INDUSTRY KEYWORDS:   Health  Biotechnology  Genetics  Pharmaceutical  Manufacturing  Engineering

MEDIA:

Logo
 Logo

Suggested Articles

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.

Novavax has brought new CMC head Machielse to head manufacturing; Rexgenero taps Wagener as CMO; EMA nominates Cooke as new director.